Sarissa Capital Management
Latest statistics and disclosures from Sarissa Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are INVA, IRWD, NBIX, CYTK, AMRN, and represent 90.38% of Sarissa Capital Management's stock portfolio.
- Added to shares of these 2 stocks: AMRN (+$6.0M), BHVN (+$5.8M).
- Started 1 new stock position in BHVN.
- Reduced shares in these 1 stock: CYTK (-$12M).
- Sarissa Capital Management was a net seller of stock by $-393k.
- Sarissa Capital Management has $223M in assets under management (AUM), dropping by 23.57%.
- Central Index Key (CIK): 0001577524
Tip: Access up to 7 years of quarterly data
Positions held by Sarissa Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 9 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Innoviva (INVA) | 25.3 | $56M | 2.8M | 19.99 |
|
|
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 24.1 | $54M | 16M | 3.37 |
|
|
| Neurocrine Biosciences (NBIX) | 19.3 | $43M | 303k | 141.83 |
|
|
| Cytokinetics Com New (CYTK) | 11.3 | $25M | -32% | 396k | 63.54 |
|
| Amarin Corp Sponsored Adr (AMRN) | 10.5 | $23M | +34% | 1.7M | 13.96 |
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 5.4 | $12M | 182k | 66.55 |
|
|
| Biohaven (BHVN) | 2.6 | $5.8M | NEW | 513k | 11.29 |
|
| Regeneron Pharmaceuticals (REGN) | 1.5 | $3.2M | 4.2k | 771.87 |
|
|
| Vor Biopharma Com New (VOR) | 0.1 | $332k | 25k | 13.08 |
|
Past Filings by Sarissa Capital Management
SEC 13F filings are viewable for Sarissa Capital Management going back to 2013
- Sarissa Capital Management 2025 Q4 filed Feb. 17, 2026
- Sarissa Capital Management 2025 Q3 filed Nov. 14, 2025
- Sarissa Capital Management 2025 Q2 filed Aug. 14, 2025
- Sarissa Capital Management 2025 Q1 filed May 15, 2025
- Sarissa Capital Management 2024 Q4 filed Feb. 14, 2025
- Sarissa Capital Management 2024 Q3 filed Nov. 14, 2024
- Sarissa Capital Management 2024 Q2 filed Aug. 14, 2024
- Sarissa Capital Management 2024 Q1 filed May 15, 2024
- Sarissa Capital Management 2023 Q4 filed Feb. 14, 2024
- Sarissa Capital Management 2023 Q3 filed Nov. 14, 2023
- Sarissa Capital Management 2023 Q2 filed Aug. 14, 2023
- Sarissa Capital Management 2023 Q1 filed May 15, 2023
- Sarissa Capital Management 2022 Q4 filed Feb. 14, 2023
- Sarissa Capital Management 2022 Q3 filed Nov. 14, 2022
- Sarissa Capital Management 2022 Q2 filed Aug. 15, 2022
- Sarissa Capital Management 2022 Q1 filed May 16, 2022